bioMérieux S.A. (BIM.PA)

EUR 102.1

(0.79%)

Market Cap (In EUR)

12.04 Billion

Revenue (In EUR)

3.67 Billion

Net Income (In EUR)

357.6 Million

Avg. Volume

86.37 Thousand

Currency
EUR
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
88.25-111.5
PE
-
EPS
-
Beta Value
0.219
ISIN
FR0013280286
CUSIP
F1149Y232
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
Mr. Pierre Boulud
Employee Count
-
Website
https://www.biomerieux.com
Ipo Date
2004-07-07
Details
bioMérieux S.A. develops and produces in vitro diagnostic solutions for the diagnosis of infectious diseases in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers systems, which use biological samples to diagnose infectious diseases, cardiovascular pathologies, and various cancers; and microbiological testing of manufacturing primarily for food, pharmaceutical, cosmetics, and veterinary sectors. It serves clinical and hospital laboratories, physicians, blood banks, and industrial control laboratories. The company was formerly known as B-D Mérieux. bioMérieux S.A. was founded in 1963 and is headquartered in Marcy l'Etoile, France. bioMérieux S.A. is a subsidiary of Institut Mérieux SA.